Epidemiology and Population Health Panel
Aim
The aim of the Epidemiology and Population Health Panel is to investigate schizophrenia and related disorders at a population level. This includes the examination of antecedents, risk and protective factors; morbidity and mortality profiles; health and well-being indicators; the impact of various treatments, clinical service innovations and other interventions; and predictors of course and outcome.
A Schizophrenia Library will also be developed and maintained to provide up-to-date reliable information about all aspects of schizophrenia for scientists, clinicians, health administrators, consumer and carer groups, and the general public, with the aims of helping to inform policy and clinical guideline development and to frame pertinent research questions.
Panel Members
Prof Vaughan Carr, University of New South Wales
Mr Daren Draganic, Schizophrenia Research Institute
Dr Irina Dedova, University of Western Sydney
Ms Liesl Duffy, Schizophrenia Research Institute
Dr Melissa Green, University of New South Wales
Ms Felicity Harris, University of New South Wales
Dr Frini Karayanidis, University of Newcastle
Dr Matthew Large, Prince of Wales Hospital
Prof Rhoshel Lenroot, University of New South Wales
Dr Carmel Loughland, Schizophrenia Research Institute
Ms Sandra Matheson, Schizophrenia Research Institute
Prof Vera Morgan, University of Western Australia
Dr Olav Nielssen, St Vincent�s Hospital
Ms Alana Shepherd, Schizophrenia Research Institute
Dr Nadia Solowij,University of Wollongong
Dr Glen Smith, Northern Sydney Central Coast Area Health Service
Note: Please visit our research database, Brain Works, for information on every Schizophrenia Research Institute supported study.
Click here to return to Research Program.
|
|
